Chandigarh, India

Suneet Kaur

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2017.


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suneet Kaur: Innovator in Biocatalysis

Introduction

Suneet Kaur is a prominent inventor based in Chandigarh, India. He has made significant contributions to the field of biocatalysis, particularly in the development of innovative methods for producing enantiomerically enriched alcohols. His work is crucial for various industrial applications, especially in pharmaceuticals.

Latest Patents

Suneet Kaur holds a patent for "Designer cells for enantioselective reduction of ketones and use thereof in efficient production of enantioenriched alcohols." This invention provides a preparation of variant recombinant whole cell biocatalysts, referred to as 'designer cells,' which exhibit significantly enhanced carbonyl reductase activity. The primary focus of this patent is the efficient production of optically pure ethyl (S)-4-chloro-3-hydroxybutyrate, a valuable chiral building block and intermediate for the production of hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors.

Career Highlights

Suneet Kaur is associated with the Council of Scientific and Industrial Research, where he has been instrumental in advancing research in biocatalysis. His innovative approach has garnered attention in the scientific community, leading to advancements in the production of important industrial chemicals.

Collaborations

Suneet has collaborated with notable colleagues, including Gautam Srivastava and Ravinder Singh Jolly. These collaborations have further enhanced the impact of his research and innovations in the field.

Conclusion

Suneet Kaur's contributions to biocatalysis and his innovative patent demonstrate his commitment to advancing scientific research. His work not only benefits the pharmaceutical industry but also showcases the potential of biocatalysts in producing valuable chemical compounds.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…